_PRIVATE_LIMITED.webp)
Rekvina Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.50 M
- Revenue Growth -64.75%
- Profit Growth -1256.63%
- Ebitda -1226.27%
- Net Worth -2084.19%
- Total Assets -21.36%
About Rekvina Pharmaceuticals (India)
Rekvina Pharmaceuticals (India) Private Limited (RPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 May 2007 and has a history of 17 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹7.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mukesh Shah, Amit Shah, and Surbhit Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230MH2007PTC170589
- Company No.
170589
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Rekvina Pharmaceuticals (India) Private Limited offer?
Rekvina Pharmaceuticals (India) Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Herbal Piles Medicine, Herbal Piles Capsules and Tablets, Nutraceuticals, Pancreatin Tablets, Common Disease Medicines, Antihistamines.
Who are the key members and board of directors at Rekvina Pharmaceuticals (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surbhit Shah  | Director | 04-May-2007 | Current |
| Mukesh Shah | Director | 04-May-2007 | Current |
| Amit Shah | Director | 20-Sep-2024 | Current |
Financial Performance of Rekvina Pharmaceuticals (India).
Rekvina Pharmaceuticals (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 64.75% decrease. The company also saw a substantial fall in profitability, with a 1256.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2084.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rekvina Pharmaceuticals (India)?
In 2020, Rekvina Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pansoft Data Solutions Private LimitedAmit Shah is a mutual person
Rekvina Laboratories LimitedMukesh Shah and Amit Shah are mutual person
Radiant Parenterals LimitedMukesh Shah, Amit Shah and 1 more are mutual person
- Varshaben Mukeshbhai Shah Foundation
Mukesh Shah, Amit Shah and 1 more are mutual person
- Phc Buildcon Private Limited
Amit Shah and Surbhit Shah are mutual person
- Cognibyte Solutions Private Limited
Amit Shah is a mutual person
Charges (Loans)
₹0
₹7.50 M
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 May 2010 | Bank Of Baroda | ₹7.50 M | Satisfied |
How Many Employees Work at Rekvina Pharmaceuticals (India)?
Rekvina Pharmaceuticals (India) has a workforce of 47 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rekvina Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rekvina Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.